DOI: http://dx.doi.org/10.18203/issn.2455-4529.IntJResDermatol20183174

A rare case report of progressive symmetric erythrokeratoderma in five generations of an Indian family

Anil Kumar Gupta, Kanishk Utkarsh Kaushik, Sushantika ., Shivangi Sachan

Abstract


Erythrokeratoderma is a rare group of disorders of autosomal dominant inheritance characterised by localised erythema and hyperkeratosis. Within a broad spectrum of phenotypes atleast two are delineated: a) Erythrokeratoderma variabilis and b) Progressive symmetric erythrokeratoderma. Here we are reporting a case of progressive symmetric erythrokeratoderma in an Indian family where five successive generations were involved.


Keywords


Erythrokeratoderma, Five generations, Autosomal dominant, Progressive symmetric erythrokeratoderma

Full Text:

PDF

References


Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K. Fitzpatrick’s Dermatology In General Medicine. Eighth edition. Chapter 49. The Ichthyoses. Mc Graw Hill Publishers; 2012.

Darier J. Progressive symmetric erythrokeratoderma verrucosa. Bull Soc Fr Dermatol Syphiligr. 1911;22:252-64.

Khoo BP, Tay YK, Tan SH. Generalized erythematous plaques. Progressive symmetric erythrokeratoderma (PSEK) (erythrokeratodermia progressive symmetrica). Arch Dermatol. 2000;136:665-8.

Available at: https://rarediseases.org/rare-diseases/ progressive-symmetric-erythrokeratodermia/NORD. Accessed on 3 March 2018.

van Steensel MA, Oranje AP, van der Schroeff JG, Wagner A, van Geel M, et al. The missense mutation G12D in connexion 30.3 can cause both erythrokeratodermia variabilis of Mendes da Costa and progressive symmetric erythrokeratodermia of Gottron. Am J Med Genet A. 2009;149:657-61.

Suga Y, Jarnik M, Attar PS, Longley MA, Bundman D, Steven AC, et al. Transgenic mice expressing a mutant form of loricrin reveal the molecular basis of the skin diseases, Vohwinkel syndrome and progressive symmetric erythrokeratoderma. J Cell Biol. 2000;151:401-12.

Bilgin L, Bozdag KE, Uysal S, Ermete M. Progressive symmetrical erythrokeratoderma – Response to topical calcipotriol. J Dermatol Case Rep. 2011;3:50-2.